Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

921
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
921
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

716
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
716
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

777
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
777
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

1.3K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.3K
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

1.0K
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.0K
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

1.2K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bucket Handle Injury in Blunt Abdominal Trauma.

Clinical practice and cases in emergency medicine·2026
Same author

Bullous Pemphigoid Causing Successive Emergency Department Visits.

Clinical practice and cases in emergency medicine·2024
Same author

Bilateral Luxatio Erecta Humeri.

Clinical practice and cases in emergency medicine·2021
Same author

COVID-19 with Hypoxic Respiratory Failure.

Clinical practice and cases in emergency medicine·2020
Same author

Author Response to: "Randomized Controlled Trial of Simulation vs Standard Training for Teaching Medical Students High-quality Cardiopulmonary Resuscitation: The Methodological Issue".

The western journal of emergency medicine·2019
Same author

Feasibility of Telesimulation and Google Glass for Mass Casualty Triage Education and Training.

The western journal of emergency medicine·2019

Related Experiment Video

Updated: Jul 23, 2025

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

9.9K

Anticholinergic Toxicity in the Emergency Department.

C Eric McCoy1, Reid Honda2

  • 1University of California, Irvine, Department of Emergency Medicine, Orange, CA.

Journal of Education & Teaching in Emergency Medicine
|July 19, 2023
PubMed
Summary

This simulation trains medical professionals to recognize and manage anticholinergic toxicity, a common emergency department presentation. Early identification and appropriate management are crucial for patient outcomes in anticholinergic poisoning.

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.1K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

30.5K

Related Experiment Videos

Last Updated: Jul 23, 2025

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

9.9K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.1K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

30.5K

Area of Science:

  • Medical Education
  • Toxicology
  • Emergency Medicine

Background:

  • Over 600 compounds possess anticholinergic properties, found in common medications and illicit substances.
  • Anticholinergic toxicity presents with diverse symptoms, including agitation, seizures, hyperthermia, and cardiac dysrhythmias, posing a significant challenge in emergency settings.
  • Familiarity with managing anticholinergic toxidrome is essential for emergency physicians due to frequent encounters.

Purpose of the Study:

  • To develop and evaluate a simulation case for training healthcare professionals in managing anticholinergic toxicity.
  • To enable learners to describe clinical presentations, identify causative agents, recognize ECG findings, and review management strategies for anticholinergic toxicity.

Main Methods:

  • A high- or moderate-fidelity manikin simulation was employed for the educational scenario.
  • The simulation was piloted with emergency medicine residents and subsequently tested on over 100 learners.
  • Learner feedback was collected via oral feedback and debriefing sessions utilizing techniques like advocacy/inquiry.

Main Results:

  • The simulation case was well-received by learners, who found it useful and engaging.
  • Learners reported positive overall feedback, indicating the case's effectiveness in their training.
  • The simulation proved effective when combined with structured debriefing sessions.

Conclusions:

  • This simulation effectively enhances the ability of medical professionals to evaluate and manage anticholinergic toxicity.
  • The training approach, incorporating manikin simulation and debriefing, is a valuable tool for improving preparedness in toxicology emergencies.
  • Continued use and refinement of such simulation-based education can improve patient care for anticholinergic poisoning.